China Biotech Services Holdings Limited reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was HKD 130.56 million compared to HKD 384.09 million a year ago. Net loss was HKD 15.38 million compared to net income of HKD 34.94 million a year ago.

Basic loss per share from continuing operations was HKD 0.016 compared to basic earnings per share from continuing operations of HKD 0.036 a year ago.